HPP737

DRUG3 trials

Sponsors

Newsoara Biopharma Co., Ltd.

Conditions

Psoriasis

Phase 3

HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.

CompletedNCT07712705

Newsoara Biopharma Co., Ltd.Psoriasis

Start: 2023-04-20End: 2025-02-20Updated: 2026-08-03

HPP737 in Adult Patients With Plaque Psoriasis

CompletedNCT07712731

Newsoara Biopharma Co., Ltd.Psoriasis

Start: 2025-04-18End: 2026-04-01Updated: 2026-08-03

Unknown Phase

HPP737 Substance Balance Study in Human

Not yet recruitingNCT06584058

Newsoara Biopharma Co., Ltd.Psoriasis

Start: 2024-08-30End: 2025-08-30Target: 8Updated: 2024-09-04